Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform Mako and its broad product portfolio.

Roper (ROP) gains from solid momentum in its businesses, acquired assets and shareholder-friendly moves. However, rising operating costs and high...

Axon Enterprise (AXON) gains from strength across its businesses, product introductions and complementary acquisitions. Rising costs and expenses may...

Axon Enterprise (AXON) gains from strength across its businesses, product introductions and complementary acquisitions. Rising costs and expenses may...

Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segment raise optimism. However, macro issues raise concerns.

Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However,...

Teleflex (TFX) holds strong momentum in the Interventional arm and a favorable solvency. Yet, macroeconomic impacts and competitive environment...

Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues pose...

Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.